Zimmer's iASSIST Knee not a threat to MAKO, says William Blair William Blair views Zimmer's (ZMH) iASSIST Knee, as a threat to MAKO Surgical's partial]knee business at present. The firm believes it will take several years for Zimmer to develop the clinical data necessary for surgeons to feel comfortable using the product. William Blair expects MAKO will begin to start meeting or exceeding consensus expectations and keeps an Outperform rating on the stock.
News For MAKO;ZMH From The Last 14 Days
Check below for free stories on MAKO;ZMH the last two weeks.
On The Fly: Analyst Upgrade Summary Today's noteworthy upgrades include: Achillion (ACHN) upgraded to Buy from Hold at Deutsche Bank... CNOOC (CEO) upgraded to Neutral from Underperform at Credit Suisse... Dollar General (DG) upgraded to Buy from Neutral at Sterne Agee... Equity Residential (EQR) upgraded to Hold from Underperform at Jefferies... HMS Holdings (HMSY) upgraded to Overweight from Equal Weight at First Analysis... HP (HPQ) upgraded to Buy from Neutral at Monness Crespi... Halcon Resources (HK) upgraded to Buy from Hold at MLV & Co.... KapStone (KS) upgraded to Buy from Hold at Deutsche Bank... Sportsman's Warehouse (SPWH) upgraded at RW Baird... Westlake Chemical (WLK) upgraded to Neutral from Reduce at SunTrust... WisdomTree (WETF) upgraded to Neutral from Sell at Citigroup... Zimmer (ZMH) upgraded to Outperform from Market Perform at William Blair.
Zimmer upgraded to Outperform from Market Perform at William Blair William Blair upgraded Zimmer Holdings to Outperform citing the recent pullback in shares and its belief the proposed Biomet acquisition will close.